Abstract
COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. Graphical Plain Language Summary: [Figure not available: see fulltext.]
Author supplied keywords
Cite
CITATION STYLE
Shin, R. K., Rammohan, K. W., & Williams, M. J. (2021, December 1). Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis. Neurology and Therapy. Adis. https://doi.org/10.1007/s40120-021-00266-z
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.